Cargando…

Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577526/
https://www.ncbi.nlm.nih.gov/pubmed/37522269
http://dx.doi.org/10.1111/acel.13945
_version_ 1785121343946096640
collection PubMed
description
format Online
Article
Text
id pubmed-10577526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105775262023-10-17 Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway Aging Cell Corrigenda John Wiley and Sons Inc. 2023-07-31 /pmc/articles/PMC10577526/ /pubmed/37522269 http://dx.doi.org/10.1111/acel.13945 Text en © 2023 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigenda
Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title_full Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title_fullStr Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title_full_unstemmed Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title_short Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway
title_sort corrigendum to: acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: involvement of rhoa/rock2 pathway
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577526/
https://www.ncbi.nlm.nih.gov/pubmed/37522269
http://dx.doi.org/10.1111/acel.13945